Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 796.60
Bid: 796.40
Ask: 796.80
Change: 7.40 (0.94%)
Spread: 0.40 (0.05%)
Open: 795.60
High: 798.00
Low: 794.20
Prev. Close: 789.20
WPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPSP 2013 - 17

14 Mar 2018 15:52

RNS Number : 7524H
WPP PLC
14 March 2018
 

For Immediate Release

14 March 2018

 

WPP PLC ("WPP")

 

EPSP 2013 - 17

 

· WPP's Executive Performance Share Plan ("EPSP") is the performance-based, management incentive compensation plan designed to incentivise long-term performance and to focus on long-term retention and strategic priorities.

· First five-year outcome under the EPSP which was designed following shareowner consultation and approved by shareowners in June 2013

· Measures performance achievement equally across three key areas; earnings growth, capital effectiveness and share price growth using EPS growth, Return-on-Equity, Relative TSR metrics.

· Relates to five-year performance period 2013-17 over which:

o Market capitalisation increased by 51.6% from £11.23bn to £17.03bn while the FTSE 100 rose by 30.3%

o £1,000 invested in WPP on 1 January 2013 increased to £1,510 by end of 2017 compared with £1,303 if invested in the FTSE 100

o EPS grew by 64.0% from 73.4p to 120.4p - a CAGR of 10.4%

o RoE averaged 15.8%

· Share price weakness to date, post the 2013-17 performance period, has been reflected in the value received by executives in the current awards vesting and will be in future cycles of the EPSP.

 

 

Introduction

WPP's EPSP was approved by shareowners in June 2013 and today's announcement is the first five-year outcome under the EPSP. The arithmetic application of the EPSP metrics has resulted in a vesting of 72.8% of the maximum.

 

The outcome results in the vesting of 858,730 shares for Sir Martin Sorrell, CEO, which were valued at £10.0m at the vesting price of £11.655435 per share on 13 March 2018.

 

This covers a five-year performance period in which the FTSE 100 rose 30.3% while WPP's shares rose 51.0%. £1,000 invested in WPP at the start of the period increased to £1,510 by the end of 2017 compared with £1,303 if invested in the FTSE 100. WPP's market capitalisation increased by 51.6% to £17.03 billion ($23.0 billion). The decline in WPP's share price since the end of the 2013-17 performance period has been reflected in the value received by executives in the current awards vesting and will be in future cycles of the EPSP.

 

 

Directors' Interests

On 13 March 2018 Sir Martin Sorrell exercised his option to receive 858,730 shares which vested pursuant to his award granted under the EPSP in 2013. On 13 March 2018 Sir Martin Sorrell sold 401,771 of these shares to raise £4.68m to discharge the consequential tax liabilities.

 

At today's date Sir Martin Sorrell and his family interests are interested in or have rights in 18,540,315 shares. Sir Martin Sorrell's family interests and rights represent 1.463% of the issued share capital of WPP. Additionally the JMCMRJ Sorrell Foundation holds 4,575,936 WPP shares, representing 0.361% of WPP's issued share capital.

 

On 13 March 2018 Mr Paul Richardson, CFO, exercised his option to receive the shares which vested pursuant to the award granted under the EPSP in 2013 in relation to 216,600 shares and sold all of these shares after exercise.

 

At today's date Mr Paul Richardson's beneficial holding is the equivalent of 1,068,240 shares (all being in WPP ADRs), representing 0.084% of WPP's issued share capital.

 

 

 

For further information please contact:

 

Richard Oldworth, Buchanan

+44 (0)207 466 5000 or +44 (0)7710 130 634

 

 

 

 

Notes to Editors

 

· The participants include the two Executive Directors as disclosed in this announcement and many of the senior executives responsible for some of the Group's largest operating companies.

· Over the performance period 2013-2017 share owner value has been created by:

Market capitalisation increasing by £5.8bn ($4.7bn)

Dividends of £2.772bn ($4.018bn) - representing 16.1% CAGR in dividend per share from 28.51p to 60.0p

Share buy-backs of £2.227bn ($3.277bn)

 

Key Financials 2013-17

 

2012

2017

Increase (%)

CAGR (%)

Revenue (£'m)

10,373

15,265

47.2

8.0

Revenue less Pass-Through Costs (£'m)

9,515

13,140

38.1

6.7

P.B.I.T (£'m)

1,531

2,267

48.1

8.2

Headline Diluted EPS (p)

73.4

120.4

64.0

10.4

Dividend (p)

28.51

60.0

110.5

16.1

Share Price (p)

888

1,341

51.0

 

Market Capitalisation (£'bn)

11.23

17.03

51.6

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSSVRWWAOAAR
Date   Source Headline
2nd Apr 20241:45 pmRNSTotal Voting Rights and Capital
21st Mar 20245:00 pmRNSAnnual Report 2023 on Form 20-F
21st Mar 20244:19 pmRNSAnnual Report 2023 and AGM Notice
21st Mar 20241:19 pmRNSNotification of Trading Update
18th Mar 20244:31 pmRNSVesting of executive share award
13th Mar 20245:10 pmRNSExecutive Performance Share Awards
13th Mar 20245:10 pmRNSVesting of executive share awards
1st Mar 202411:08 amRNSTotal Voting Rights and Capital
27th Feb 20246:08 pmRNSNotification of Major Holdings
22nd Feb 20247:00 amRNS2023 Preliminary Results
8th Feb 20248:00 amRNSInvestment
7th Feb 202410:29 amRNSNotification of Major Holdings
1st Feb 202412:42 pmRNSTotal Voting Rights and Capital
30th Jan 20247:00 amRNSCapital Markets Day 2024
12th Jan 202412:45 pmRNSNotification of CMD and 2023 Preliminary Results
2nd Jan 20243:03 pmRNSTotal Voting Rights and Capital
11th Dec 20234:38 pmRNSDirector / PDMR Transaction notification
11th Dec 20233:02 pmRNSNotification of Major Holdings
8th Dec 202311:47 amRNSExecutive Share Awards
1st Dec 20235:04 pmRNSTotal Voting Rights and Capital
21st Nov 20231:05 pmRNSAcquisition
16th Nov 20233:23 pmRNSDIRECTOR / PDMR TRANSACTION NOTIFICATION
1st Nov 20232:17 pmRNSTotal Voting Rights and Capital
26th Oct 20237:00 amRNSThird Quarter Trading Update
10th Oct 20234:59 pmRNSNotification of Trading Update
2nd Oct 202311:58 amRNSTotal Voting Rights and Capital
7th Sep 20232:49 pmRNSBoard Change
1st Sep 20239:57 amRNSTotal Voting Rights and Capital
7th Aug 20233:01 pmRNSDirector / PDMR Transaction notification
4th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:18 pmRNSTotal Voting Rights and Capital
11th Jul 202312:36 pmRNSNotification of Interim Results
3rd Jul 202311:50 amRNSTotal Voting Rights and Capital
20th Jun 20231:00 pmRNSAcquisition
1st Jun 202310:48 amRNSTotal Voting Rights and Capital
17th May 20232:46 pmRNSResults of AGM
16th May 202312:00 pmRNSVesting of executive share award
9th May 20234:15 pmRNSExecutive Share Awards
2nd May 202311:11 amRNSTotal Voting Rights and Capital
27th Apr 20237:00 amRNSFirst Quarter Trading Update
20th Apr 202311:00 amRNSAcquisition
11th Apr 202310:30 amRNSUpdate re FGS Global
3rd Apr 202312:50 pmRNSTotal Voting Rights and Capital
28th Mar 202310:40 amRNSNotification of Trading Update
27th Mar 20233:00 pmRNSAcquisition
27th Mar 20232:41 pmRNSExecutive Performance Share Awards
24th Mar 20237:00 amRNSAnnual Report 2022 on Form 20-F
23rd Mar 20234:21 pmRNSAnnual Report 2022 and AGM Notice
23rd Mar 202311:15 amRNSBoard Change
22nd Mar 202312:46 pmRNSCFO Transition Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.